Gastric cancer staging is frequently limited by the low sensitivity of routine imaging for occult peritoneal metastasis (OPM), necessitating invasive staging laparoscopy. We developed a Multimodal Model, integrating primary tumor radiomics from CT with clinical factors to non-invasively predict OPM in locally advanced gastric cancer. The model was trained and internally validated in a large cohort (n = 940) and externally validated across two independent multi-center cohorts (n = 309), an incremental cohort (n = 477), and a prospective clinical trial cohort (n = 168). In all cohorts, the model achieved robust performance (AUCs: 0.834-0.857), significantly outperforming single-modality models. Crossover validation showed AI assistance increased the average radiologist AUC from 0.735 to 0.872. Transcriptomic analysis revealed that the model's low-risk stratification correlated with an enhanced antitumor immune microenvironment (CD8 T cells, TNFα signaling). This validated model provides a practical tool for accurate, non-invasive OPM prediction and individualized treatment planning.
© 2026. The Author(s).